You're receiving this email because you're subscribed to Ring the Bell from Benzinga. To manage your subscription, click the link at the bottom of this email.

Happy Friday, Zingernation! When I say I’m ‘down bad’ it’s usually because I’ve had too much to drink the night before. But hey, at least I’m not losing billions of dollars trying to short the hottest stock in the market.

–Aaron Bry & Nic Chahine

Today’s Price Action:

$SPY: -.13%
$QQQ: -.27%
$DIA: +.04%

Plus, this biotech company just received a fast-track designation for its pancreatic cancer treatment.

TODAY’S MOST VOLATILE STOCKS

TODAY’S TOP STORY

Cyberattacks Stall Car Dealerships: Dealers React To 'Inexcusable' Outages With No End In Sight

What Happened: Approximately 15,000 car dealerships throughout the U.S. that use CDK Global, a private software company, had their services disrupted following cyberattacks on CDK Global’s platform on Wednesday.

So: According to Axios, CDK told customers on Thursday that it did “not have an estimated time frame for resolution and therefore our dealers’ systems will not be available likely for several days.”

Basically: Dealers are now using pen and paper rather than computer systems for several functions. Some routine actions, such as title work, cannot be done amid the outage. Here are some other companies that have recently dealt with cyberattacks.

PRESENTED BY THERIVA BIOLOGICS

Theriva™ Biologics Receives Fast Track Designation By The U.S. FDA For VCN-01 And Its Use In Treating Metastatic Pancreatic Cancer

Theriva™ Biologics, an immuno-oncology company developing oncolytic viruses, otherwise known as cancer cell-infecting viruses, to overcome the protective barrier surrounding solid tumors and selectively kill tumor cells has achieved a significant milestone as the U.S. FDA has granted Fast Track Designation (FTD) to their VCN-01 treatment.

Theriva Biologics’ approach to cancer treatment differentiates it from its peers, potentially placing the company in a unique market position. As incidences of pancreatic cancer continue to rise globally, drug treatment options, such as VCN-01, will likely rise in demand. With VCN-01 receiving FTD from the U.S. FDA, this milestone speaks to the drug's efficacy and long-run potential.

ONE TRADE IDEA FOR NEXT WEEK

YouTube Steps Up Ad-Blocker Crackdown: Is It Making A Difference?

Briefly: YouTube, Alphabet Inc‘s video streaming platform, is reportedly experimenting with new ways to prevent rampant ad-blocking on the platform.

What Happened: SponsorBlock, a crowdsourced Google Chrome extension designed to bypass sponsored content, reported on YouTube’s latest crackdown in a post on X, formerly known as Twitter.

So: YouTube is reportedly experimenting with server-side ad injection, a method to prevent ad-blocking overrides like SponsorBlock. The platform will insert ad-related material directly into the video stream instead of on top of the video stream. Will the efforts help boost YouTube’s revenue and thus Alphabet’s stock?

PRESENTED BY DIREXION

Level Up Your Trading with Leveraged ETFs

Level Up Your Trading with Leveraged ETFs is a virtual bootcamp led by analysts from Direxion. Join this live bootcamp to deepen your understanding of leveraged and inverse ETFs and learn how to successfully trade them. With expert-led sessions and live case studies, this bootcamp offers an immersive learning experience you don’t want to miss out on.

Date: Tuesday, June 25, 2024
Time: 11:00 AM - 12:30 PM EST

Click here to register.

BEFORE YOU GO

Were you forwarded this email? Click here to subscribe.

And be sure to check out our other newsletters:

Future Finance: Where fintech, crypto, and the future of finance collide. Future Finance is a perfect lunch read packed with quick bites for industry enthusiasts. Subscribe here.

Cannabis Daily: A must-read daily briefing for cannabis investors, operators, and enthusiasts. Join our list of industry veterans to jump start your morning. Subscribe here.

Real Estate Weekly: Where we highlight the movers and the losers, the upgrades and the downgrades, the top stories and opportunities in the trillion dollar REIT and real asset industry. Subscribe here.

Mining Weekly: Get an insider's edge with news, analysis, and commentary on what’s shaping the mining and commodities industry that powers the global economy. Subscribe here.

^{Disclaimer: Alternative investments are speculative and possess a high level of risk. No assurance can be given that investors will receive a return of their capital. Those investors who cannot afford to lose their entire investment should not invest. Investments in private placements are highly illiquid and those investors who cannot hold an investment for an indefinite term should not invest. Private credit investments may be complex investments and they are subject to default risk.}